This MedLibrary.org supplementary page on GSK-3 is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (February 2008) |
| Identifiers | |
| Symbol | GSK3A |
| Entrez | 2931 |
| HUGO | 4616 |
| OMIM | 606784 |
| RefSeq | NM_019884 |
| UniProt | P49840 |
| Other data | |
| EC number | 2.7.11.26 |
| Locus | Chr. 19 q13 |
| Identifiers | |
| Symbol | GSK3B |
| Entrez | 2932 |
| HUGO | 4617 |
| OMIM | 605004 |
| RefSeq | NM_002093 |
| UniProt | P49841 |
| Other data | |
| Locus | Chr. 3 q13.3 |
Glycogen synthase kinase 3 (GSK-3) is a serine/threonine protein kinase, which means that it mediates the addition of phosphate molecules on certain serine and threonine amino acids in particular cellular substrates. The phosphorylation of these other proteins by GSK-3 usually inhibits the target protein (as in the case of glycogen synthase and NFAT; the target protein is also called the "substrate").[1][2][3] In mammals GSK-3 is encoded by two known genes GSK-3 Alpha and Beta.
Contents |
Function
As mentioned, GSK-3 is known for phosphorylating and thus inactivating glycogen synthase. It has also been implicated in the control of cellular response to damaged DNA. GSK-3's homolog in the fruit fly Drosophila melanogaster is known as Shaggy (Zeste White 3). In Drosophila and the frog Xenopus laevis GSK-3 works in the Wnt signalling pathway to phosphorylate β-catenin. Phosphorylation leads to ubiquitination and degradation by cellular proteases, preventing it from entering the nucleus and activating transcription factors. When a protein called Disheveled is activated by Wnt signalling, GSK-3 is inactivated, allowing β-catenin to accumulate and effect transcription of Wnt target genes. GSK-3 also phosphorylates Ci in the Hedgehog (Hh) pathway, targeting it for proteolysis to an inactive form.
In addition to glycogen synthase, GSK-3 has many other substrates. However, GSK-3 is unusual among the kinases in that it usually requires a "priming kinase" to first phosphorylate a substrate, and then, only when the priming kinase has done its job can GSK-3 additionally phosphorylate the substrate.
The consequence of GSK-3 phosphorylation is usually inhibition of the substrate. For example, when GSK-3 phosphorylates another of its substrates, the NFAT family of transcription factors, these transcription factors can not translocate to the nucleus and are therefore inhibited.
In addition to its important role in the Wnt signalling pathway, which is required for establishing tissue patterning during development, GSK-3 is also critical for the protein synthesis that is induced in settings such as skeletal muscle hypertrophy. Its roles as an NFAT kinase also places it as a key regulator of both differentiation and cellular proliferation.
GSK-3 inhibition
GSK-3 can be inhibited by AKT phosphorylation, which is part of the insulin signal transduction. Therefore, Akt is an activator of many of the signaling pathways blocked by GSK-3. For example, in the setting where Akt signaling is induced, it can be shown that NFAT is dephosphorylated.
Experimentally, it has been shown that certain concentrations of lithium chloride (LiCl) and/or 6-bromoindirubin-3'-oxime (BIO) will inhibit GSK3B.[4] in the Wnt signaling pathway. This inhibition of GSK-3 is currently believed to underlie the therapeutic usefulness of lithium salts for the treatment of mood disorders.[5]
Furthermore, cytokine-dependent GSK-3 phosphorylation in hemopoietic cells may regulate growth, and the PKC family of kinases may play a key role in GSK-3 phosphorylation.[6]
References
- ^ Woodgett JR (August 1994). "Regulation and functions of the glycogen synthase kinase-3 subfamily". Semin. Cancer Biol. 5 (4): 269–75. PMID 7803763.
- ^ Woodgett JR (September 2001). "Judging a protein by more than its name: GSK-3". Sci. STKE 2001 (100): RE12. doi:. PMID 11579232.
- ^ Ali A, Hoeflich KP, Woodgett JR (August 2001). "Glycogen synthase kinase-3: properties, functions, and regulation". Chem. Rev. 101 (8): 2527–40. PMID 11749387.
- ^ Klein PS, Melton DA. (1996). "A molecular mechanism for the effect of lithium on development". Proc Natl Acad Sci U S A. 93 (16): 8455–9. doi:. PMID 8710892.
- ^ Kaladchibachi SA, Doble B, Anthopoulos N, Woodgett JR, Manoukian AS. (2007). "Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium". J Circadian Rhythms. 5: 3. doi:. PMID 17295926.
- ^ Vilimek D, Duronio V (February 2006). "Cytokine-stimulated phosphorylation of GSK-3 is primarily dependent upon PKCs, not PKB". Biochem. Cell Biol. 84 (1): 20–9. doi:. PMID 16462886.
External links
|
|||||||||||
|
||||||||
 |
This transferase article is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 24 September 2008, at 02:41.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "GSK-3".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.